AI Science Tracker

Tencent AI Lab

1 discovery from 2024

Discoveries

Generative antibody language model yields a pseudovirus-neutralizing XBB spike binder

Tencent AI Lab and collaborators developed PALM-H3, a pretrained antibody language model that generates heavy-chain CDRH3 sequences, and A2binder to rank antigen-antibody binding. For SARS-CoV-2 XBB, which the paper says was not present during training, the selected generated antibody (Artificial 1) bound spike and neutralized pseudovirus in vitro, with reported KD 0.13 nM and IC50 0.00301 μg/mL. The study also assayed generated antibodies against wild-type, Alpha and Delta; performance varied by antibody and variant.

Technology: PALM-H3 pretrained antibody generative language model and A2binder antigen-antibody affinity predictor

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: For SARS-CoV-2 XBB, which the paper says was not present during training, the selected generated antibody (Artificial 1) bound spike and neutralized pseudovirus in vitro, with reported KD 0.13 nM and IC50 0.00301 μg/mL.
  • Still unknown: The functional evidence is in vitro, using SARS-CoV-2 pseudovirus rather than live-virus or clinical outcomes. The study tested selected antibody candidates; several generated candidates performed substantially worse, so the reported top result is not representative of all generated sequences. The stated novelty is experimental neutralization against the XBB variant by a generated antibody, not proof of a treatment or protection in people.
  • AI role: PALM-H3 generated CDRH3 sequences conditioned on antigen specificity using a RoFormer-based antibody model; A2binder scored antibody-antigen pairs to select candidates for binding, surface-plasmon-resonance and pseudovirus neutralization tests. The paper reports it generated and selected an XBB spike-binding antibody despite XBB being absent from its training set.

Evidence sources: https://www.nature.com/articles/s41467-024-50903-y

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 80 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.